A carregar...
Quantitative examination of the inhibitory activation of molecular targeting agents in hepatocellular carcinoma patient‐derived cell invasion via a novel in vivo tumor model
BACKGROUND: The outcomes for patients with advanced hepatocellular carcinoma (HCC) receiving sorafenib are far from satisfactory because of treatment resistance to sorafenib. However, the exact mechanism of resistance to sorafenib remains unclear and it is valuable to establish a novel mouse model t...
Na minha lista:
| Publicado no: | Animal Model Exp Med |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6930997/ https://ncbi.nlm.nih.gov/pubmed/31942558 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ame2.12085 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|